A U.S. regulatory decision on tolebrutinib will again be delayed while a late-stage trial of the drug for a different form of ...

Sanofi-Aventis U.S. was hit with a consumer class action Thursday in California Northern District Court over the company's hydrocortisone-based products. The complaint, which was brought by Francis ...

Sanofi announces availability of Q4 2025 Aide memoire on the company's website for financial modeling purposes. Q4 2025 results to be published on January 29, 2026 ...

Drugmaker Sanofi-Aventis employs 100,000 people worldwide, but it is the 66 employees at its Oro Valley research center who have developed about half of the company's drug compounds. The ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

(RTTNews) - Sanofi-Aventis Groupe announced positive results from the pivotal LUNA 3 phase 3 study of rilzabrutinib in adults with persistent or chronic immune thrombocytopenia (ITP), a rare ...

(RTTNews) - The U.S. Food and Drug Administration has accepted for priority review the Biologics License Application (BLA) for efanesoctocog alfa (BIVV001) for the treatment of hemophilia A, a rare ...

Deal covers two research-stage small molecules that restore p53 function. Sanofi-Aventis has obtained an exclusive, worldwide license covering two anticancer agents from Ascenta Therapeutics. The ...

WASHINGTON, Sept 10 (Reuters) - A U.S. subsidiary of drugmaker Sanofi-Aventis has paid about $190 million to federal and state governments to settle charges that it overcharged Medicare for an ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

PARIS/LONDON, Jan 29 (Reuters) - Sanofi-Aventis and Bristol-Myers Squibb Co could announce a friendly merger deal within the next few weeks to create the world's biggest drugs company, according to a ...

A federal jury came back with a defense verdict late Thursday night after two weeks of trial in New Orleans. The jury found Sanofi-Aventis, which has U.S. headquarters in New Jersey, had not failed to ...